Epilepsy in Children and Youth: Advanced Program

Young husband and wife with their young daughter of 3 years-old

This series builds on the foundational curriculum and aims to develop proficiency in the management of epilepsy.

MAY 11 – JUNE 22, 2023 | 12:00 PM – 1:00 PM EST | WEEKLY

This program explores a range of complex topics such as drug resistant epilepsy, polypharmacy, genetics, ketogenic diet, and more. This program is intended for clinicians who are seeking to further their competencies in epileptology.

  • Next Session

    June 1, 2023

    12:00 pm 1:00 pm

    Advanced S4 | Medical Cannabis Therapy

This Quick Study series is facilitated by The Hospital for Sick Children (SickKids).

Children's Hospital, London Health Sciences Centre


This Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by Continuing Professional Development, Faculty of Medicine, University of Toronto for up for up to 1.0 Mainpro+ credits.

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by Continuing Professional Development, Faculty of Medicine, University of Toronto. You may claim a maximum of 1.0 hours.

  • Identify evidence-supported indications and dosing
  • Recognize common drug-drug interactions and side effects
  • Recognize epilepsy can be a genetic condition
  • Identify patients with epilepsy that may benefit from genetic testing
  • Describe the process of genetic testing for epilepsy in Ontario
  • Describe the underlying mechanism of the ketogenic diet
  • Identify how the diet is monitored in children with epilepsy
  • Recognize clinical considerations for ketogenic diet as a treatment option for children living with epilepsy
  • Identify the evidence-supported indications and dosing for cannabinoid therapy in epilepsy
  • Recognize common drug-drug interactions, side effects, and practical considerations in using cannabinoids in pediatric epilepsy
  • Describe the ways in which healthcare professionals can support and facilitate families in accessing medical cannabis
  • Identify drug resistant epilepsy (DRE)
  • Recognize when to refer to a paediatric epilepsy program, referral pathways available in Ontario
  • Describe the importance of counseling regarding DRE
  • Recognize that epilepsy can be caused by autoimmune conditions
  • Identify patients that can benefit from autoimmune testing
  • Discuss the process to obtain autoimmune testing
  • Identify the most common psychiatry and somatic co-morbidities associated to epilepsy
  • Classify the appropriate tests and procedures for a child presenting with a seizure and/or epilepsy
  • Recognize the difference between work up for acute symptomatic seizure vs. that for suspected epilepsy
  • Identify the clinical use and limitations of EEG in the diagnosis and management of epilepsy
  • Describe the merits of various neuroimaging techniques in epilepsy and their indications

Clinical Leads

Dr. Andrea Andrade

Dr. Andrea Andrade, Paediatric Epileptologist

Medical Lead